Silence Therapeutics (SLN) Gross Profit (2020 - 2026)
Silence Therapeutics recorded quarterly Gross Profit of $411000.0 in Q1 2026, up 1768.18% quarter-over-quarter from $22000.0 in Q4 2025, and up 367.05% year-over-year from $88000.0 in Q1 2025.
Silence Therapeutics' Gross Profit history runs 7 years deep, the most recent figure standing at $411000.0 for Q1 2026.
- In Q1 2026, Gross Profit rose 367.05% year-over-year to $411000.0; the TTM figure through Mar 2026 stood at $667000.0 (down 96.42% YoY), while the FY2025 annual figure was $344000.0, down 98.91% from the prior year.
- Gross Profit came in at $411000.0 for Q1 2026 at Silence Therapeutics, up from $22000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $23.3 million in Q4 2024 to a low of -$2.6 million in Q2 2024.
- A 5-year average of $3.5 million and a median of $1.1 million in 2022 frame the typical range for Gross Profit.
- Across the five-year window, Gross Profit soared 208630.27% in 2022 and plunged 241.92% in 2024, its largest moves.
- Silence Therapeutics' Gross Profit stood at $1.1 million in 2022, then retreated by 12.05% to $934587.4 in 2023, then surged by 2389.55% to $23.3 million in 2024, then slumped by 99.91% to $22000.0 in 2025, then jumped by 1768.18% to $411000.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $411000.0, $22000.0, and $95000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411,000.00 |
| Mar 31, 2026 | 411,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 23.27 Mn |
| Dec 31, 2024 | 23.27 Mn |
| Sep 30, 2024 | -2.14 Mn |
| Sep 30, 2024 | -2.14 Mn |
| Jun 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -2.58 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 934,587.37 |
| Dec 31, 2023 | 934,587.37 |
| Sep 30, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 8.31 Mn |
| Mar 31, 2023 | 8.31 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 4.63 Mn |
| Mar 31, 2022 | 4.63 Mn |
| Dec 31, 2021 | -4,835.31 Bn |
| Dec 31, 2021 | -4,835.31 Bn |
| Sep 30, 2021 | 1,521.96 Bn |
| Sep 30, 2021 | 1,521.96 Bn |
| Jun 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.22 Mn |
| Mar 31, 2021 | 2,215.93 |
| Mar 31, 2021 | 2,215.93 |
| Dec 31, 2020 | 2.27 Mn |
| Dec 31, 2020 | 2.27 Mn |
| Sep 30, 2020 | -442.64 Mn |
| Sep 30, 2020 | -442.64 Mn |